药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Iron Dextran
Lurasidone
The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Mibefradil.
Iron Dextran
Orphenadrine
The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Mibefradil.
Iron Dextran
Felbamate
The risk or severity of QTc prolongation can be increased when Felbamate is combined with Mibefradil.
Iron Dextran
Vilanterol
The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Mibefradil.
Iron Dextran
Sevoflurane
The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Mibefradil.
Iron Dextran
Inotersen
The risk or severity of QTc prolongation can be increased when Inotersen is combined with Mibefradil.
Iron Dextran
Pipemidic acid
The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Mibefradil.
Iron Dextran
Rufloxacin
The risk or severity of QTc prolongation can be increased when Rufloxacin is combined with Mibefradil.
Iron Dextran
Piromidic acid
The risk or severity of QTc prolongation can be increased when Piromidic acid is combined with Mibefradil.
Iron Dextran
Oxolinic acid
The risk or severity of QTc prolongation can be increased when Oxolinic acid is combined with Mibefradil.
Iron Dextran
Givinostat
The risk or severity of QTc prolongation can be increased when Givinostat is combined with Mibefradil.
Iron Dextran
Temefos
The risk or severity of QTc prolongation can be increased when Temefos is combined with Mibefradil.
Iron Dextran
Delafloxacin
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Mibefradil.
Iron Dextran
Prulifloxacin
The risk or severity of QTc prolongation can be increased when Prulifloxacin is combined with Mibefradil.
Iron Dextran
CUDC-907
The risk or severity of QTc prolongation can be increased when CUDC-907 is combined with Mibefradil.
Iron Dextran
Pazufloxacin
The risk or severity of QTc prolongation can be increased when Pazufloxacin is combined with Mibefradil.
Iron Dextran
Bilastine
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Mibefradil.
Iron Dextran
Difloxacin
The risk or severity of QTc prolongation can be increased when Difloxacin is combined with Mibefradil.
Iron Dextran
Sarafloxacin
The risk or severity of QTc prolongation can be increased when Sarafloxacin is combined with Mibefradil.
Iron Dextran
Phosmet
The risk or severity of QTc prolongation can be increased when Phosmet is combined with Mibefradil.